AIM: To gauge patient interest in receiving long-acting injectable nanoformulated antiretroviral therapy. METHODS: Four hundred adult HIV-infected patients currently prescribed antiretroviral therapy were surveyed. χ(2) tests were used for comparisons of interest across groups. RESULTS: Respondents were 68% male and 53% African-American, with a mean age of 47 years. Overall, 73% of patients indicated that they would definitely or probably try injectable nanoformulated antiretroviral therapy; 61% with weekly dosing; 72% every 2 weekly; and 84% monthly. In total, 48% indicated that they were very concerned about the possible side effects and 35% were very concerned about needle use. CONCLUSION: The majority of respondents indicated that they definitely or probably would try parenteral nanoformulated antiretroviral therapy.
AIM: To gauge patient interest in receiving long-acting injectable nanoformulated antiretroviral therapy. METHODS: Four hundred adult HIV-infectedpatients currently prescribed antiretroviral therapy were surveyed. χ(2) tests were used for comparisons of interest across groups. RESULTS: Respondents were 68% male and 53% African-American, with a mean age of 47 years. Overall, 73% of patients indicated that they would definitely or probably try injectable nanoformulated antiretroviral therapy; 61% with weekly dosing; 72% every 2 weekly; and 84% monthly. In total, 48% indicated that they were very concerned about the possible side effects and 35% were very concerned about needle use. CONCLUSION: The majority of respondents indicated that they definitely or probably would try parenteral nanoformulated antiretroviral therapy.
Authors: D L Paterson; S Swindells; J Mohr; M Brester; E N Vergis; C Squier; M M Wagener; N Singh Journal: Ann Intern Med Date: 2000-07-04 Impact factor: 25.391
Authors: Prasanta K Dash; Howard E Gendelman; Upal Roy; Shantanu Balkundi; Yazen Alnouti; Rodney L Mosley; Harris A Gelbard; Joellyn McMillan; Santhi Gorantla; Larisa Y Poluektova Journal: AIDS Date: 2012-11-13 Impact factor: 4.177
Authors: Frederick L Altice; Adeeba Kamarulzaman; Vincent V Soriano; Mauro Schechter; Gerald H Friedland Journal: Lancet Date: 2010-07-31 Impact factor: 79.321
Authors: Robert C Bollinger; Chloe L Thio; Mark S Sulkowski; Jane McKenzie-White; David L Thomas; Charles Flexner Journal: Lancet HIV Date: 2019-12-20 Impact factor: 12.767
Authors: Iwona Cicha; Cédric Chauvierre; Isabelle Texier; Claudia Cabella; Josbert M Metselaar; János Szebeni; László Dézsi; Christoph Alexiou; François Rouzet; Gert Storm; Erik Stroes; Donald Bruce; Neil MacRitchie; Pasquale Maffia; Didier Letourneur Journal: Cardiovasc Res Date: 2018-11-01 Impact factor: 10.787
Authors: John M Cortez; Rafaela Quintero; John A Moss; Martin Beliveau; Thomas J Smith; Marc M Baum Journal: Antimicrob Agents Chemother Date: 2014-10-13 Impact factor: 5.191
Authors: Ethel D Weld; Md Sohel Rana; Ronald H Dallas; Andres F Camacho-Gonzalez; Patrick Ryscavage; Aditya H Gaur; Rana Chakraborty; Susan Swindells; Charles Flexner; Allison L Agwu Journal: J Acquir Immune Defic Syndr Date: 2019-02-01 Impact factor: 3.731
Authors: Manjula Gunawardana; Mariana Remedios-Chan; Christine S Miller; Rob Fanter; Flora Yang; Mark A Marzinke; Craig W Hendrix; Martin Beliveau; John A Moss; Thomas J Smith; Marc M Baum Journal: Antimicrob Agents Chemother Date: 2015-04-20 Impact factor: 5.191
Authors: S Swindells; M Siccardi; S E Barrett; D B Olsen; J A Grobler; A T Podany; E Nuermberger; P Kim; C E Barry; A Owen; D Hazuda; C Flexner Journal: Int J Tuberc Lung Dis Date: 2018-02-01 Impact factor: 2.373
Authors: Pavan Puligujja; Shantanu S Balkundi; Lindsey M Kendrick; Hannah M Baldridge; James R Hilaire; Aditya N Bade; Prasanta K Dash; Gang Zhang; Larisa Y Poluektova; Santhi Gorantla; Xin-Ming Liu; Tianlei Ying; Yang Feng; Yanping Wang; Dimiter S Dimitrov; JoEllyn M McMillan; Howard E Gendelman Journal: Biomaterials Date: 2014-12-09 Impact factor: 12.479
Authors: Lisa A McConnachie; Loren M Kinman; Josefin Koehn; John C Kraft; Sarah Lane; Wonsok Lee; Ann C Collier; Rodney J Y Ho Journal: J Pharm Sci Date: 2018-03-13 Impact factor: 3.534